Mental Health

Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approved

LONDON, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient...

Psyence Group Inc Subsidiary Psyence Biomedical Ltd. announces signing of definitive agreement for a convertible note in connection with planned business combination

TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc ("Psyence Group") (CSE:PSYG), a clinical-stage life science biotechnology company pioneering...

NextGen Healthcare Selected by Spectrum Healthcare to Help Address Shortage of Primary and Behavioral Health Professionals

Technology Investments to Support Leading Arizona-based Nonprofit’s Delivery of Whole-Person CareREMOTE-FIRST COMPANY/PHOENIX--(BUSINESS WIRE)--#NextGenHealthcare--Working to address Arizona’s shortage of primary and...

error: Content is protected !!